Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyl-D-Aspartic Acid-Reference-Cited by-同舟云学术

Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyl-D-Aspartic Acid

Published:2011-08 Issue:2 Volume:113 Page:405-411
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:

Author:

Gu XiaoPing,Mei FengMei,Liu Yue,Zhang Rui,Zhang Juan,Ma ZhengLiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference36 articles.

1. The endocannabinoid system as an emerging target of pharmacotherapy.;Pacher;Pharmacol Rev,2006

2. Cannabinoid receptors and pain.;Pertwee;Prog Neurobiol,2001

3. CB2 receptor cannabinoid receptor-mediated peripheral antinociception.;Malan;Pain,2001

4. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.;Valenzano;Neuropharmacology,2005

5. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 receptor cannabinoid receptors.;Quartilho;Anesthesiology,2003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microglia Promote Inhibitory Synapse Phagocytosis in the Spinal Cord Dorsal Horn and Modulate Pain-Like Behaviors in a Murine Cancer-Induced Bone Pain Model;Anesthesia & Analgesia;2024-01-19

2. Peripherally administered cannabinoid receptor 2 (CB2R) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG;Brain Research;2022-01

3. Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review;Process Biochemistry;2021-12

4. Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1;Drug Design, Development and Therapy;2021-11

5. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases;International Journal of Molecular Sciences;2021-08-31